Understanding the role of vagal FFAR3 in regulating glucose homeostasis

了解迷走神经 FFAR3 在调节葡萄糖稳态中的作用

基本信息

  • 批准号:
    10207515
  • 负责人:
  • 金额:
    $ 3.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-15 至 2023-09-14
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSRACT The goal of this F31 application is to elucidate the roles and mechanisms of FFAR3 signaling in the vagus nerve in regulating glucose homeostasis. Proper regulation of energy metabolism requires sensing of nutrient and hormonal cues to coordinate an appropriate behavioral and physiological response. Vagus nerve sensing of dietary nutrients or nutrient-stimulated hormones has been demonstrated to regulate food intake, glucose homeostasis, and gut motility. The gut microbiome ferments soluble non-digestible fiber to release short-chain fatty acids (SCFA’s) which can serve as signaling molecules through G-protein coupled receptors. The SCFA’s, including acetate, propionate, and butyrate can bind free fatty acid receptor 2 (FFAR2) and 3 (FFAR3). Increasing dietary fiber intake or directly supplementing SCFA’s has been shown to improve host glucose homeostasis, but the molecular mechanisms mediating these effects are unclear. Direct vagal sensing of gut microbiome produced SCFA’s via FFAR3 could contribute to regulation of glucose metabolism. We found that propionate was decreased in the plasma of western diet (WD)-fed mice compared to normal chow (NC)-fed controls. When obese mice received oral gavages of fecal microbiome transplantations (FMT) from lean NC-fed donors, their plasma propionate levels increased, and fasting blood glucose decreased. Directly supplementing propionate in the water of WD- fed mice lowered fasting glucose and improved glucose tolerance. Propionate is the most potent known endogenous ligand for FFAR3, and FFAR3 KO mice exhibit disrupted glucose tolerance, so we hypothesized that FFAR3 expressed on the vagus nerve connects microbiome-produced propionate and central nervous system control of glucose homeostasis. Indeed, we found Ffar3 to be actively translated in vagal sensory neurons. Treatment of vagal cultures with the FFAR3 ligand, propionate, activated the neurons and increased neuronal translation of Glp1r. Vagal GLP1R function and expression is dysregulated in rodent models of obesity, but the molecular mechanisms are not well understood. We hypothesize that propionate signals through FFAR3 in the vagus nerve to increase Glp1r expression and improve glucose homeostasis. We will test this hypothesis through the following aims. Aim 1 will assess if propionate activates vagal neurons and increases Glp1r translation via FFAR3 in vagal organotypic cultures. We will accomplish this by utilizing the ribotag genetic mouse model which allows for cell-specific assessment of genes in translation. We will assess translation of glucoregulatory genes after propionate stimulation in vagal ganglia expressing FFAR3, and ganglia from FFAR3KO mice. Aim 2 will assess whether vagal FFAR3 is required for propionate to improve glucose intolerance in vivo in WD-fed male and female mice. To accomplish this, we will utilize a novel FFAR3 floxed mouse model and genetically ablate FFAR3 only from vagal neurons. We will challenge control and vagal FFAR3KO mice with a western diet, supplemented with either saline or propionate, to determine if propionate improves WD-induced glucose intolerance via FFAR3. Overall, we expect this study to improve the understanding of how propionate and FFAR3 contribute to autonomic control of glucose homeostasis and energy balance. The proposed study will elucidate new signaling pathways for the treatment of type 2 diabetes.
项目概要/摘要 该 F31 应用的目标是阐明 FFAR3 信号在迷走神经调节中的作用和机制 葡萄糖稳态。能量代谢的正确调节需要感知营养和激素信号来协调 适当的行为和生理反应。迷走神经感知饮食营养或营养刺激 激素已被证明可以调节食物摄入、葡萄糖稳态和肠道蠕动。肠道微生物组 发酵可溶性不可消化纤维,释放短链脂肪酸 (SCFA),可作为信号分子 通过G蛋白偶联受体。 SCFA,包括乙酸盐、丙酸盐和丁酸盐,可以结合游离脂肪酸 受体 2 (FFAR2) 和 3 (FFAR3)。增加膳食纤维摄入量或直接补充 SCFA 已被证明可以 改善宿主葡萄糖稳态,但介导这些作用的分子机制尚不清楚。直接迷走神经感应 肠道微生物组通过 FFAR3 产生 SCFA 可能有助于调节葡萄糖代谢。我们发现 与正常饲料(NC)喂养的对照组相比,西方饮食(WD)喂养的小鼠血浆中丙酸盐含量降低。什么时候 肥胖小鼠接受来自瘦 NC 喂养供体的粪便微生物组移植 (FMT) 的口服强饲,其血浆 丙酸水平升高,空腹血糖降低。直接在WD-水中添加丙酸盐 喂食的小鼠降低了空腹血糖并改善了葡萄糖耐量。丙酸是已知最有效的内源配体 对于 FFAR3,FFAR3 KO 小鼠表现出葡萄糖耐量破坏,因此我们假设 FFAR3 在 迷走神经连接微生物组产生的丙酸盐和控制葡萄糖稳态的中枢神经系统。的确, 我们发现 Ffar3 在迷走神经感觉神经元中积极翻译。用 FFAR3 配体处理迷走神经培养物, 丙酸,激活神经元并增加 Glp1r 的神经元翻译。迷走神经GLP1R的功能和表达是 肥胖啮齿动物模型中失调,但其分子机制尚不清楚。我们假设 丙酸信号通过迷走神经中的 FFAR3 增加 Glp1r 表达并改善葡萄糖稳态。我们 将通过以下目标来检验这一假设。目标 1 将评估丙酸盐是否激活迷走神经元并增加 Glp1r 在迷走神经器官培养中通过 FFAR3 进行翻译。我们将通过利用核糖核酸标签基因小鼠来实现这一目标 允许对翻译中的基因进行细胞特异性评估的模型。我们将评估葡萄糖调节基因的翻译 在表达 FFAR3 的迷走神经节和 FFAR3KO 小鼠的迷走神经节中进行丙酸刺激后。目标 2 将评估 丙酸是否需要迷走神经 FFAR3 来改善 WD 喂养的雄性和雌性小鼠体内的葡萄糖耐受不良。 为了实现这一目标,我们将利用一种新型 FFAR3 floxed 小鼠模型,并仅从迷走神经中基因消除 FFAR3 神经元。我们将用西式饮食挑战对照和迷走神经 FFAR3KO 小鼠,辅以生理盐水或 丙酸盐,以确定丙酸盐是否通过 FFAR3 改善 WD 诱导的葡萄糖不耐受。总的来说,我们期望这项研究 提高对丙酸和 FFAR3 如何促进葡萄糖稳态自主控制的理解 能量平衡。拟议的研究将阐明治疗 2 型糖尿病的新信号通路。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tyler Cook其他文献

Tyler Cook的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tyler Cook', 18)}}的其他基金

Understanding the role of vagal FFAR3 in regulating glucose homeostasis
了解迷走神经 FFAR3 在调节葡萄糖稳态中的作用
  • 批准号:
    10471225
  • 财政年份:
    2020
  • 资助金额:
    $ 3.69万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了